Skip to content

Mesa Laboratories MLAB Cash & Equivalents

Cash & Equivalents at other companies

3M logo
3MMMM
$3.73B-41.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3.28B-21.4%
Danaher logo
DanaherDHR
$5.7B+186%
STERIS logo
STERISSTE
$439.6M+156%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$509M-2.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$198.2M-14.5%

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's cash & equivalents?
Mesa Laboratories (MLAB) reported cash & equivalents of $26.93M in Q1 2026.
How has Mesa Laboratories's cash & equivalents changed year-over-year?
Mesa Laboratories's cash & equivalents decreased by 1.4% year-over-year, from $27.32M to $26.93M.
What is the long-term trend for Mesa Laboratories's cash & equivalents?
Over 3 years (2021 to 2026), Mesa Laboratories's cash & equivalents has grown at a -53.3% compound annual growth rate (CAGR), from $263.87M to $26.93M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.